[The influence of hyperthyroidism and glucocorticoids on bone metabolism].
Kulig
Grzegorz
G
Klinika Endokrynologii, Nadciśnienia Tetniczego i Chorób Przemiany Materii PAM w Szczecinie.
Kaźmierczyk-Puchalska
Agnieszka
A
Pynka
Sławomir
S
Pilarska
Krystyna
K
D000469:Alkaline Phosphatase / Q000378:metabolism; D013956:Antithyroid Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000378:metabolism*; D002118:Calcium / Q000097:blood; D003480:Cushing Syndrome / Q000150:complications* / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D008297:Male; D010024:Osteoporosis / Q000209:etiology* / Q000378:metabolism; D010758:Phosphorus / Q000097:blood
D013956:Antithyroid Agents; D015415:Biomarkers; D016207:Cytokines; D005938:Glucocorticoids; D010758:Phosphorus; D000469:Alkaline Phosphatase; D002118:Calcium